Defective lymphoid organogenesis underlies the immune deficiency caused by a heterozygous S32I mutation in IκBα
View/ Open
Author
Mooster, Jana L.
Le Bras, Severine
Jabara, Haifa
Yoon, Juhan
Heesters, Balthasar A.
Mattoo, Hamid
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1084/jem.20140979Metadata
Show full item recordCitation
Mooster, J. L., S. Le Bras, M. J. Massaad, H. Jabara, J. Yoon, C. Galand, B. A. Heesters, et al. 2015. “Defective lymphoid organogenesis underlies the immune deficiency caused by a heterozygous S32I mutation in IκBα.” The Journal of Experimental Medicine 212 (2): 185-202. doi:10.1084/jem.20140979. http://dx.doi.org/10.1084/jem.20140979.Abstract
Patients with ectodermal dysplasia with immunodeficiency (ED-ID) caused by mutations in the inhibitor of NF-κB α (IκBα) are susceptible to severe recurrent infections, despite normal T and B cell numbers and intact in vitro lymphocyte function. Moreover, the outcome of hematopoietic stem cell transplantation (HSCT) in these patients is poor despite good engraftment. Mice heterozygous for the IκBα S32I mutation found in patients exhibited typical features of ED-ID. Strikingly, the mice lacked lymph nodes, Peyer’s patches, splenic marginal zones, and follicular dendritic cells and failed to develop contact hypersensitivity (CHS) or form germinal centers (GCs), all features not previously recognized in patients and typical of defective noncanonical NF-κB signaling. Lymphotoxin β receptor (LTβR)–driven induction of chemokines and adhesion molecules mediated by both canonical and noncanonical NF-κB pathways was impaired, and levels of p100 were markedly diminished in the mutant. IκBα mutant→Rag2−/−, but not WT→IκBα mutant, bone marrow chimeras formed proper lymphoid organs and developed CHS and GCs. Defective architectural cell function explains the immunodeficiency and poor outcome of HSCT in patients with IκBα deficiency and suggests that correction of this niche is critical for reconstituting their immune function.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322042/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:21462389
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)